EFFECTS OF A POTASSIUM-SPARING THIAZIDE DIURETIC COMBINATION ON CARDIOVASCULAR REACTIVITY TO VASOPRESSOR AGENTS

被引:4
|
作者
SCHOHN, DC [1 ]
JAHN, HA [1 ]
机构
[1] UNIV STRASBOURG 1,DEPT NEPHROL & HEMODIALYSIS,F-67070 STRASBOURG,FRANCE
来源
AMERICAN JOURNAL OF CARDIOLOGY | 1990年 / 65卷 / 23期
关键词
D O I
10.1016/0002-9149(90)91270-G
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The vascular effects of a diuretic combination (spironolactone/altizide) were studied in S anuric patients undergoing dialysis by measuring changes in cardiovascular reactivity to norepinephrine (NE) and angiotensin II (AII) after infusion of incremental doses of these 2 vasopressor agents. There was a marked dose-response relation between NE and AII administration and mean (NE) or diastolic (AII) blood pressure (BP). Diuretic treatment moderated the increase in mean or diastolic BP induced by NE or AII. In addition, the pressor doses of NE and AII, which are also parameters of vascular reactivity, were significantly increased after diuretic treatment (NE, +101%; AII, +163%). Right atrial and pulmonary capillary wedge pressures increased along with BP in response to NE. Diuretic treatment also moderated the increase in right atrial and pulmonary capillary wedge pressures induced by NE. These results suggest that the antihypertensive action of spironolactone and altizide in combination is mainly due to a direct effect on resistance and capacitance vessels. The mechanisms by which diuretics modify the cardioreactivity remain poorly understood; however, they may modify electrolyte transport (sodium and calcium) across vascular smooth muscle cell membranes or stimulate postaglandin release. © 1990.
引用
收藏
页码:K14 / K17
页数:4
相关论文
共 50 条
  • [21] Effects of Potassium-Sparing Versus Thiazide Diuretics on Glucose Tolerance New Data on an Old Topic
    Elliott, William J.
    HYPERTENSION, 2012, 59 (05) : 911 - 912
  • [22] ATTENUATION OF DIURETIC-INDUCED HYPOKALEMIA BY AMILORIDE, A POTASSIUM-SPARING AGENT
    RAM, CVS
    HOLLAND, OB
    KAPLAN, NM
    JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (11-1): : 484 - 487
  • [23] TREATMENT OF ESSENTIAL-HYPERTENSION WITH A POTASSIUM-SPARING DIURETIC COMBINATION - RESULTS OF A GERMAN MULTICENTER STUDY WITH MODURETIC
    HAIMERL, F
    LEHMANN, K
    KOPCKE, W
    FORTSCHRITTE DER MEDIZIN, 1985, 103 (34) : 812 - 816
  • [24] EFFECTS OF AMILORIDE, A POTASSIUM-SPARING DIURETIC, ON INOTROPIC RESPONSES OF ISOLATED GUINEA-PIG ATRIA
    POUSTI, A
    KHOYI, MA
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1977, 9 : 46 - 46
  • [25] Thiazide diuretics alone or in combination with a potassium-sparing diuretic on blood pressure-lowering in patients with primary hypertension: protocol for a systematic review and network meta-analysis
    Vítor M. Martins
    Patrícia K. Ziegelmann
    Lucas Helal
    Filipe Ferrari
    Marcelo B. Lucca
    Sandra C. Fuchs
    Flávio D. Fuchs
    Systematic Reviews, 11
  • [26] Thiazide diuretics alone or in combination with a potassium-sparing diuretic on blood pressure-lowering in patients with primary hypertension: protocol for a systematic review and network meta-analysis
    Martins, Vitor M.
    Ziegelmann, Patricia K.
    Helal, Lucas
    Ferrari, Filipe
    Lucca, Marcelo B.
    Fuchs, Sandra C.
    Fuchs, Flavio D.
    SYSTEMATIC REVIEWS, 2022, 11 (01)
  • [27] POTASSIUM-SPARING EFFECTS OF TRIAMTERENE IN TREATMENT OF HYPERTENSION
    SPIEKERMAN, RE
    BERGE, KG
    THURBER, DL
    GEDGE, SW
    MCGUCKIN, WF
    CIRCULATION, 1966, 34 (03) : 524 - +
  • [28] MUCOSAL IRRITANT POTENTIAL OF A POTASSIUM-SPARING DIURETIC AND OF WAX-MATRIX KCL
    RYAN, JR
    MCMAHON, FG
    AKDAMAR, K
    ERTAN, A
    AGRAWAL, N
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (01) : 90 - 93
  • [29] Potassium-sparing renal effects of trimethoprim and structural analogues
    Gabriëls, G
    Stockem, E
    Greven, J
    NEPHRON, 2000, 86 (01): : 70 - 78
  • [30] PIRETANIDE, A POTENT DIURETIC WITH POTASSIUM-SPARING PROPERTIES, FOR THE TREATMENT OF CONGESTIVE-HEART-FAILURE
    SHERMAN, LG
    LIANG, CS
    BAUMGARDNER, S
    CHARUZI, Y
    CHARDO, F
    KIM, CS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (05) : 587 - 594